Diagnosis and Treatment of Dysthymia in Children and Adolescents

CNS Drugs

Volumn 17, Issue 13, 2003, Pages 927-946

  Nobile, Maria ^a   Cataldo, Giulia M ^a   Marino, Cecilia ^a   Molteni, Massimo ^a  

^a SCIENTIFIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENT; AGITATION; ALGORITHM; CARDIOTOXICITY; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSTHYMIA; FAMILY THERAPY; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; HYPOMANIA; INSOMNIA; IRRITABILITY; MANIA; MENTAL HEALTH; MOOD DISORDER; NAUSEA; PRIORITY JOURNAL; PSYCHOTHERAPY; RASH; RELAPSE; REVIEW; SEDATION; SOCIAL ADAPTATION; SOCIAL PSYCHOLOGY; SUSTAINED RELEASE PREPARATION; SWEATING; TIC; TREATMENT INDICATION; TREMOR; VERTIGO;

ADOLESCENT; CHILD; DYSTHYMIC DISORDER; HUMANS; PSYCHOTHERAPY; SEROTONIN UPTAKE INHIBITORS;

EID: 0242487608     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200317130-00001     Document Type: Review

References (107)

1. American Psychiatry Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994
2. Kovacs M, Akiskal HS, Gatsonis C, et al. Childhood-onset dysthymic disorder: clinical features and prospective naturalistic outcome. Arch Gen Psychiatry 1994; 51: 365-74
3. Lewinsohn PM, Rohde P, Seeley JR, et al. Comorbidity of unipolar depression: I. Major depression with dysthymia. J Abnorm Psychol 1991; 100: 205-13
4. Klein DN, Schwarts JE, Rose S, et al. Five-year course and outcome of dysthymic disorders: a prospective, naturalistic follow-up study. Am J Psychiatry 2000 Jun; 157: 931-9
5. Fleming JE, Offord DR. Epidemiology of childhood depressive disorders: a critical review. J Am Acad Child Adolesc Psychiatry 1990; 29: 571-80
6. Flament MF, Cohen D, Choquet M, et al. Phenomenology, psychosocial correlates and treatment seeking in major depression and dysthymia of adolescence. J Am Acad Child Adolesc Psychiatry 2001; 40 (9): 1070-8
7. Kovacs M, Obrosky DS, Gatsonis C, et al. First-episode major depressive and dysthymic disorder in childhood: clinical and sociodemographic factors in recovery. J Am Acad Child Adolesc Psychiatry 1997; 36 (6): 777-84
8. Brent DA, Kolko DJ, Birmaher B, et al. A clinical trial for adolescent depression: predictors of additional treatment in the acute and follow-up phases of the trial. J Am Acad Child Adolesc Psychiatry 1999; 38 (3): 263-70
9. Birmaher B, Arbelaez C, Brent DA. Course and outcome of child and adolescent major depressive disorder. Child Adolesc Psychiatr Clin N Am 2002; 11 (3): 619-37
10. Kovacs M. Presentation and course of major depressive disorder during childhood and later years of the life span. J Am Acad Child Adolesc Psychiatry 1996 Jun; 35 (6): 705-15
11. Keller MB, Lavori PW, Endicott J, et al. "Double depression": two-year follow-up. Am J Psychiatry 1983; 140: 689-94
12. Ferro T, Carlson GA, Grayson P, et al. Depressive disorders: distinctions in children. J Am Acad Child Adolesc Psychiatry 1994; 33: 664-70
13. Goodman SH, Schwab-Stone M, Lahey BB, et al. Major depression and dysthymia in children and adolescents; discriminant validity and differential consequences in a community sample. J Am Acad Child Adolesc Psychiatry 2000; 39: 761-70
14. American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with suicidal behavior. J Am Acad Child Adolesc Psychiatry 2001; 40 Suppl. 7: 24S-51S
15. Kovacs M, Goldston D, Gatsonis C. Suicidal behaviors and childhood-onset depressive disorders: a longitudinal investigation. J Am Acad Child Adolesc Psychiatry 1993 Jan; 32 (1): 8-20
16. Brent DA, Oquendo M, Birmaher B, et al. Familial pathways to early-onset suicide attempt. Arch Gen Psychiatry 2002; 59: 801-7
17. Kaplan SJ, Pelcovitz D, Salzinger S, et al. Adolescent physical abuse and suicide attempts. J Am Acad Child Adolesc Psychiatry 1997; 36; 799-808
18. Fergusson DM, Horwood LJ, Lynskey MT. Childhood sexual abuse and psychiatric disorder in young adulthood: II. Psychiatric outcomes of childhood sexual abuse. J Am Acad Child Adolesc Psychiatry 1996; 35 (10): 1365-74
19. Garrison CZ, Waller JL, Cuffe SP, et al. Incidence of major depressive disorder and dysthymia in young adolescents. J Am Acad Child Adolesc Psychiatry 1997; 36: 458-65
20. Klein DN, Lewinsohn PM, Seeley JR. Psychosocial characteristics of adolescents with a past history of dysthymic disorder: comparison with adolescents with past histories of major depressive and non affective disorders, and never mentally ill controls. J Affect Disord 1997; 42: 127-35
21. Olsson GI, Nordstrom ML, Arinell H, et al. Adolescent depression: social network and family climate. J Child Psychol Psychiatry 1999; 40: 227-37
22. Lewinsohn PM, Hops H, Roberts RE, et al. Adolescent psychopathology: prevalence and incidence of depression and other DSM III-R disorders in high school students. J Abnorm Psychol 1993; 102: 133-44
23. Kashani JH, Beck NC, Hoeper EW, et al. Psychiatric disorders in a community sample of adolescents. Am J Psychiatry 1987; 144: 584-9
24. Kashani JH, Carlson GA, Beck NC, et al. Depression, depressive symptoms and depressed mood among a community sample of adolescents. Am J Psychiatry 1987; 144: 931-4
25. Prescott CA, McArdle JJ, Hishinuma ES, et al. Prediction of major depression and dysthymia from CES-D scores among ethnic minority adolescents. J Am Acad Child Adolesc Psychiatry 1998; 37 (5): 495-503
26. Almqvist F, Puura K, Kumpulainen K, et al. Psychiatric disorders in 8-9 year old children based on a diagnostic interview with parents. Eur Child Adolesc Psychiatry 1999; 8 Suppl. 4: 17-28
27. Klein DK, Riso LP, Donaldson SK, et al. Family study of early onset dysthymia: mood and personality disorders in relatives of outpatients with dysthymia and episodic major depression and normal controls. Arch Gen Psychiatry 1995; 52: 487-96
28. Lizardi H, Klein DN, Outmette PC, et al. Reports of the childhood home environment in early onset dysthymia and episodic major depression. J Abnorm Psychol 1995; 104: 132-9
29. Lizardi H, Klein DN. Parental psychopathology and reports of the childhood home environment in adults with early onset dysthymic disorder. J Nerv Ment Dis 2000; 188: 63-70
30. Kaplan S, Pelcovitz D, Salzinger S, et al. Adolescent physical abuse: risk for adolescent psychiatric disorders. Am J Psychiatry 1998; 155: 954-9
31. Renouf AG, Kovacs M. Dysthymic disorder during childhood and adolescence. In: Kocsis JH, Klein DN, editors. Diagnosis and treatment of chronic depression. New York: The Guilford Press, 1995: 20-40
32. American Academy Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 1998; 37 Suppl. 10: 63S-83S
33. Keller MB, McCullough JP, Klein DN, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000 May 18; 342 (20): 1462-70
34. Brent DA, Kolko DJ, Birmaher B, et al. Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression. J Am Acad Child Adolesc Psychiatry 1998; 37: 906-14
35. Angold A, Weissman MM, John K, et al. Parent and child reports of depressive symptoms in children at low and high risk of depression. J Child Psychol Psychiatry 1987; 28: 901-15
36. Emslie GJ, Mayes TL. Depression in children and adolescents: a guide to diagnosis and treatment. CNS Drugs 1999; 11 (3): 181-9
37. Kovacs M. Children's depression inventory: CDI manual. Toronto (ON): Multi-Health System Inc, 1992
38. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278-96
39. Shaffer D, Gould MS, Brasic J, et al. A children's global assessment scale (CGAS). Arch Gen Psychiatry 1983; 40: 1228-31
40. Gowers SG, Harrington RC, Whitton A, et al. Brief scale for measuring the outcomes of emotional and behavioural disorders in children: Health of the Nation Outcome Scales for Children and Adolescents (HoNOSCA). Br J Psychiatry 1999 May; 174: 413-6
41. McCracken JT, Cantwell D. Management of child and adolescent mood disorders. Child Adolesc Psychiatr Clin N Am 1992; 1: 229-55
42. Park RJ, Goodyear IM. Clinical guidelines for depressive disorders in childhood and adolescence. Eur Child Adolesc Psychiatry 2000; 9: 147-61
43. Brent DA, Holder D, Kolko DJ, et al. A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Arch Gen Psychiatry 1997; 54: 877-85
44. Beardslee WR, Salt P, Versage EM, et al. Sustained change in parents receiving preventive interventions for families with depression. Am J Psychiatry 1997; 154: 510-5
45. Weissman MM, Warner V, Wickramaratne P, et al. Offspring of depressed parents: 10 years later. Arch Gen Psychiatry 1997; 54: 932-40
46. Fine S, Forth A, Gilbert M, et al. Group therapy for adolescent depressive disorder: a comparison of social skills and therapeutic support. J Am Acad Child Adolesc Psychiatry 1991; 30: 79-85
47. Kovacs M, Sherrill JT. The psychotherapeutic management of major depressive and dysthymic disorders in childhood and adolescence: issues and prospects. In: Goodyer IM, editor. The depressed child and adolescent. 2nd ed. Cambridge: Cambridge University Press, 2000
48. Curry JF. Specific psychotherapies for childhood and adolescent depression. Biol Psychiatry 2001; 49: 1091-100
49. Beck AT, Rush AJ, Shaw BF, et al. Cognitive therapy of depression. New York: Guilford Press, 1979
50. Lewinsohn PM, Clarke GN, Hops H, et al. Cognitive-behavioral treatment for depressed adolescents. Behav Ther 1990; 21: 385-401
51. Vostanis P, Feehan C, Grattan E, et al. Treatment for children and adolescents with depression: lessons from a controlled trial. Clin Child Psychol Psychiatry 1996; 1: 199-212
52. Wood A, Harrington R, Moore A. Controlled trial of a brief cognitive-behavioral intervention in adolescent patients with depressive disorders. J Child Psychol Psychiatry 1996; 37: 737-46
53. Clarke GN, Rohde P, Lewinsohn PM, et al. Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions. J Am Acad Child Adolesc Psychiatry 1999; 38: 272-9
54. Markowitz JC. Psychotherapy of dysthymia. Am J Psychiatry 1994; 151 (8): 1114-21
55. Fennel MJV, Teasdale JD. Cognitive therapy with chronic, drug refractory depressed outpatients: a note of caution. Cognit Ther Res 1982; 6: 455-60
56. Stravynski A, Shahar A, Verrault R. A pilot study of the cognitive treatment of dysthymic disorder. Behav Psychother 1991; 4: 369-72
57. Moreau D, Mufson L, Weissman MM, et al. Interpersonal psychotherapy for adolescent depression: description of modification and preliminary application. J Am Acad Child Adolesc Psychiatry 1991; 30: 642-51
58. Mufson L, Weissman MM, Moreau D, et al. Efficacy of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry 1999; 56: 573-9
59. Mufson L, Fairbanks J. Interpersonal psychotherapy for depressed adolescents: a one-year naturalistic follow-up study. J Am Acad Child Adolesc Psychiatry 1996; 35: 1145-55
60. Markowitz JC, Klerman GL. Manual for interpersonal psychotherapy of dysthymia, version 2.1. New York: Cornell University Medical College, Department of Psychiatry, 1993
61. Rossellò J, Bernal G. The efficacy of cognitive-behavioral and interpersonal treatments for depression in Puerto Rican adolescents. J Consult Clin Psychol 1999; 67: 734-45
62. Harrington RC. Family-genetic findings in child and adolescent depressive disorders. Int Rev Psychiatry 1996; 8: 355-68
63. Asarnow JR, Goldstein MJ, Tompson M, et al. One-year outcomes of depressive disorders in child psychiatric inpatients: evaluation of prognostic power of a brief measure of expressed emotions. J Child Psychol Psychiatry 1993; 34: 129-37
64. Harrington RC. Roles of the child and adolescent mental health service in preventing later depressive disorder: problems and prospects. Child Psychol Psychiatry Rev 1997; 2: 46-57
65. Hammen C. Depression runs in families: the social context of risk and resilience in children of depressed mothers. New York: Springer-Verlag, 1991
66. Durbin CE, Klein DN, Schwartz JE. Predicting the 21/2-year outcome of dysthymic disorder: the roles of childhood adversity and family history of psychopathology. J Consult Clin Psychol 2000; 68 (1): 57-63
67. Bemporad JR. Psychodynamic treatment of depressed adolescents. J Clin Psychiatry 1988; 48 Suppl.: 26-31
68. Clarke GN, Hawkins W, Murphy M, et al. School-based primary prevention of depressive symptomatology in adolescents: findings from two studies. J Adolesc Res 1993; 8: 183-204
69. Clarke GN, Hawkins W, Murphy M, et al. Targeted prevention of unipolar depressive disorder in an at-risk sample of high school adolescents: a randomized trial of a group cognitive intervention. J Am Acad Child Adolesc Psychiatry 1995; 34: 312-21
70. Jaycox LH, Reivich KJ, Gillham J, et al. Preventing depressive symptoms in school children. Behav Res Ther 1994; 32: 801-16
71. Dunner DL. Acute and maintenance treatment of chronic depression. J Clin Psychiatry 2001; 62 Suppl. 6: 10-6
72. Ravindran AV, Anisman H, Merali Z, et al. Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments. Am J Psychiatry 1999; 156: 1608-17
73. Ballus C, Quiros G, De Flores T, et al. The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia. Int Clin Psychopharmacol 2000; 15: 43-8
74. Hughes CW, Emslie GJ, Crismon ML, et al. The Texas children's medication algorithm project: report of the Texas Consensus Conference Panel on medication treatment of childhood major depressive disorder. J Am Acad Child Adolesc Psychiatry 1999; 38 (11): 1442-54
75. Friedman RA. Social and occupational adjustment in chronic depression. In: Kocsis JH, Klein DN, editors. Diagnosis and treatment of chronic depression. New York: The Guilford Press, 1995: 89-102
76. Kutcher S. Practitioner review: the pharmacotherapy of adolescent depression. J Child Psychol Psychiatry 1997; 38: 755-67
77. Renaud J, Axelson D, Birmaher B. A risk-benefit assessment of pharmacotherapies for clinical depression in children and adolescents. Drug Saf 1999 Jan; 20 (1): 59-75
78. Emslie GJ, Mayes TL. Mood disorders in children and adolescents: psychopharmacological treatment. Biol Psychiatry 2001; 49: 1082-90
79. Leonard HL, March J, Rickler KC, et al. Pharmacology of the selective serotonin reuptake inhibitors in children and adolescents. J Am Acad Child Adolesc Psychiatry 1997; 36 (6): 725-36
80. Waslick BD, Walsh BT, Greenhill LL, et al. Open trial of fluoxetine in children and adolescents with dysthymic disorder or double depression. J Affect Disord 1999; 56: 227-36
81. Rabe-Jablonska J. Therapeutic effects and tolerability of fluvoxamine treatment in adolescents with dysthymia. J Child Adolesc Psychopharmacol 2000; 10 (1): 9-18
82. Nobile M, Bellotti B, Marino C, et al. An open trial of paroxetine in the treatment of children and adolescents with dysthymic disorder. J Child Adolesc Psychopharmacol 2000; 10 (2): 103-9
83. Rey-Sanchez F, Gutierrez-Casares JR. Paroxetine in children with major depressive disorder: an open trial. J Am Acad Child Adolesc Psychiatry 1997; 36; 1443-7
84. Nixon MK, Milin R, Simeon JG, et al. Sertraline effects in adolescent major depression and dysthymia: a six-month open trial. J Child Adolesc Psychopharmacology 2001; 11 (2): 131-42
85. Bostic JQ, Prince J, Brown K, et al. A retrospective study of citalopram in adolescents with depression. J Child Adolesc Psychiatry 2001; 11 (2): 159-66
86. Geller G, Reising D, Leonard HL, et al. Critical review of tricyclic antidepressant use in children and adolescents. J Am Acad Child Adolesc Psychiatry 1999; 38 (5): 513-6
87. Mandocki MW, Tapia MR, Tapia MA, et al. Venlafaxine in the treatment of children and adolescent with major depression. Psychopharmacol Bull 1997; 33 (1): 149-54
88. Wilens TE, Spencer TJ, Biederman J, et al. Case study: nefazodone for juvenile mood disorders. J Am Acad Child Adolesc Psychiatry 1997; 36 (4): 481-5
89. Findling RL, Preskorn SH, Marcus RN, et al. Nefazodone pharmacokinetics in depresses children and adolescents. J Am Acad Child Adolesc Psychiatry 2000; 39 (8): 1008-16
90. Horst WD, Preskorn SH. Mechanism of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion. J Affect Disord 1998; 51: 237-54
91. Arredondo DE, Doherty J, Streeter M. Bupropion treatment of adolescent depression [abstract]. J Nat Assoc Private Psychiatric Hosp 1993 Winter/Spring: 12-3
92. Daviss WB, Bentivoglio P, Racusin R, et al. Bupropion sustained release in adolescents with comorbid attention-deficit/ hyperactivity disorder and depression. J Am Acad Child Adolesc Psychiatry 2001; 40 (3): 307-14
93. McConville BJ, Chaney RO, Browne KL, et al. Newer antidepressants: beyond selective serotonin reuptake inhibitor antidepressants. Pediatr Clin North Am 1998; 45: 1157-71
94. Crismon ML, Trivedi M, Pigott TA, et al. The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on medication treatment of major depressive disorder. J Clin Psychiatry 1999; 60: 142-56
95. Ryan ND, Meyer V, Dachille S, et al. Lithium antidepressant augmentation in TCA-refractory depression in adolescents. J Am Acad Child Adolesc Psychiatry 1988; 27: 371-6
96. Strober M, Freeman R, Rigali J, et al. The pharmacotherapy of depressive illness in adolescence: II. Effects of lithium augmentation in non responders to imipramine. J Am Acad Child Adolesc Psychiatry 1992; 31: 16-20
97. Ramasubbu R. Treatment of resistant depression by adding noradrenergic agents to lithium augmentation of SSRIs. Ann Pharmacother 2002 Apr; 36 (4): 634-40
98. Rudas S, Schmitz M, Pichler P, et al. treatment of refractory chronic depression and dysthymia with high dose thyroxine. Biol Psychiatry 1999 Jan; 45 (2): 229-33
99. Waechter F. Paroxetine must not be given to patients under 18. BMJ 2003 Jun 14; 326 (7402): 1282
100. Oxman TE, Barret JE, Sengupta A, et al. Status of minor depression and dysthymia in primary care following a randomized controlled treatment. Gen Hosp Psychiatry 2001; 23 (6): 301-10
101. Miller NL, Kocsis JH, Leon AC, et al. Maintenance desipramine for dysthymia: a placebo-controlled study. J Affect Disord 2001 May; 64 (2-3): 231-7
102. Katon W, Rutter C, Ludman EJ, et al. A randomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry 2001 Mar; 58 (3): 241-7
103. Trivedi MH, Kleiber BA. Algorithm for the treatment of chronic depression. J Clin Psychiatry 2001; 62 Suppl. 6: 22-9
104. Hellerstein DJ, Little SAS. Current perspectives on the diagnosis and treatment of double depression. CNS Drugs 1996; 5: 344-57
105. Bogetto F, Bellino S, Revello RB, et al. Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation. CNS Drugs 2002; 16 (4): 273-83
106. Masi G, Mucci M, Millepiedi S. Separation anxiety disorder in children and adolescents: epidemiology, diagnosis, and management. CNS Drugs 2001; 15 (2): 93-104
107. Kovacs M, Feinberg TL, Crouse-Novak M, et al. Depressive disorders in childhood: II. A longitudinal study of the risk for a subsequent major depression. Arch Gen Psychiatry 1984; 41: 643-9